Cullinan Management is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

www.cullinanoncology.com →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why

KBR Lands Libya Deal With Zallaf: Is the Expansion a New Growth Lever?

Globale Online (GLBE) Upgraded to Strong Buy: Here's Why

What Makes MYR Group (MYRG) a Strong Momentum Stock: Buy Now?

All You Need to Know About International Consolidated Airlines Group (ICAGY) Rating Upgrade to Strong Buy

Adecoagro (AGRO) Upgraded to Strong Buy: Here's What You Should Know

All You Need to Know About Recruit Holdings Co. (RCRUY) Rating Upgrade to Buy

Comfort Systems (FIX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Mama's Creations, Inc. (MAMA) Upgraded to Strong Buy: Here's What You Should Know

Q32 Bio (QTTB) Upgraded to Strong Buy: Here's What You Should Know

Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's Why

Blue Bird (BLBD) Upgraded to Strong Buy: Here's What You Should Know

HBT Financial (HBT) Upgraded to Buy: Here's What You Should Know

Quebec Innovative Materials Corp. to Host Live X Spaces Q&A on DDH-26-02 Results from West Advocate Hydrogen Project, Nova Scotia

Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange

Glencore could walk away from South Africa smelter rescue talks over conditions

Novo Nordisk's Higher Dose Wegovy Weight-Loss Drug Gains U.S. Approval

Oracle Pushes Up Capex Spending on AI: High Risk or High Reward?

Darden Q3 Earnings Meet Estimates, Revenues Top, Both Rise Y/Y

How Much Does Management Matter For A Publicly Traded Company?

About